Anemias Archives | Report Store | Pharma intelligence

show blocks helper

Sort by Default

Display 15 Products per page

Disease Analysis: Anemia in Chronic Kidney Disease
Read More
Chronic kidney disease (CKD) is characterized by decreased kidney function and kidney damage. Damaged renal tissue has a diminished ability to produce erythropoietin, a hormone that stimulates red blood cell production.
November 20, 2020
Find out more
Market Spotlight: Chemotherapy-Induced Anemia

$1,318.00

This Market Spotlight report covers the chemotherapy-induced anemia market, comprising key marketed and pipeline drugs, clinical trials, regulatory events, probability of success, epidemiology information, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
November 12, 2020
Find out more
Market Spotlight: Sickle Cell Anemia

$1,318.00

This Market Spotlight report covers the Sickle Cell Anemia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease prevalence forecast, and licensing and acquisition deals.
November 5, 2020
Find out more
Market Spotlight: Cold Agglutinin Disease

$1,318.00

This Market Spotlight report covers the Cold Agglutinin Disease market, comprising key pipeline drugs, clinical trials, probability of success, and an epidemiology overview.
October 22, 2020
Find out more
Chemotherapy-Induced Anemia Market and Forecast Analysis to 2027
Read More
Anemia is a common complication in cancer patients, and can arise due to the malignancy itself (cancer-related anemia), or chemotherapy treatment (chemotherapy-induced anemia [CIA]).
May 2, 2018
Find out more

Anemias

Disease Analysis: Anemia in Chronic Kidney Disease

Market Spotlight: Chemotherapy-Induced Anemia

Market Spotlight: Sickle Cell Anemia

Market Spotlight: Cold Agglutinin Disease

Chemotherapy-Induced Anemia Market and Forecast Analysis to 2027